Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn how to identify key budget categories and monitor them effectively. A concise guide to staying on top of your spending and maximizing savings.
24,745 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
An in-depth look at Workhorse's path in 2026, focusing on earnings potential, drivers, and strategies for investors n...
Looking to secure the best mortgage rate in 2026? This practical guide breaks down the steps that save you money: sha...
Northrop Grumman shares are rising on a new Air Force contract to speed up B-21 production, signaling upside not yet ...
A single headline about 500 million barrels can spark fear or opportunity in oil investing. This article unpacks what...
Two very different computer vision players sit at automation's frontier. This guide weighs Aeva Technologies and Cogn...
A major enforcement push in Louisiana led to 21 new arrests in a Medicaid fraud crackdown. This article explains what...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
Tesla’s ambitious software push could reshape profits, but regulatory headwinds loom. This guide helps news tesla sha...
SpaceX is aiming for a trillion-dollar-scale future by combining AI, orbital data, and lunar infrastructure. This art...
Bitcoin has fallen about 20% in the last 30 days, shaking investors and raising questions about what comes next. This...